Does a combined gait training with the Incedo improve walking performance and gait parameters in chronic patients with stroke-induced hemiparesis? Chronic outpatient stroke patients will be recruited for the study. The study consists of pre- and post-assessments as well as a 5-week training period. During the pre- and post-assessment sessions, patients will undergo motor tests and a gait analysis. During the 5-week training period, patients will receive gait training combined with electrical stimulation (Incedo™) of the affected leg for 45 minutes, three times per week.

Does a combined gait training with the Incedo improve walking performance and gait parameters in chronic patients with stroke-induced hemiparesis? Chronic outpatient stroke patients will be recruited for the study. The study consists of pre- and post-assessments as well as a 5-week training period. During the pre- and post-assessment sessions, patients will undergo motor tests and a gait analysis. During the 5-week training period, patients will receive gait training combined with electrical stimulation (Incedo™) of the affected leg for 45 minutes, three times per week. - Gait Training in Chronic Stroke Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00036294

Enrollment

Registered

2025-04-03

Start date

2022-04-18

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I60 I61 I62 I63 I64

Interventions

Group 1: All patients underwent gait training combined with reflex-based electrotherapy for 15 sessions. Throughout the study, assessments were conducted at five distinct times: initially at baseline

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Stroke > 6 months ago Patients > 18 years old • Ability to consent to participate in the study and follow instructions • Ability to communicate that the training session should be ended • Ability to walk at least 10 meters with or without assistance • Patient is able to tolerate electrical stimulation • Ability to completely lift the sole of the foot off the ground (at least 1 cm) • Visible response to electrical stimulation

Exclusion criteria

Exclusion criteria: • More than one stroke in history, unless the patient had no neurological deficits from previous strokes. • Patients with poor compliance Epilepsy • Patients with pacemakers • Patients with heart or lung diseases • Skin lesions/local infections in the area of the sole of the foot where the electrodes are placed • Other neurological disorders • Pregnancy • The application of electrical stimulation is only carried out with the explicit consent of the specialist doctor

Design outcomes

Primary

Measure	Time frame
During the study, evaluations were conducted at five different time points: initially as a baseline (T0), five weeks later as a second baseline (T1), after completing five weeks of therapy (T2), following a 12-week follow-up period (T3), and one year after the intervention (T4). a. 2-minute walk test with and without Incedo® (measured in meters) b. 10-meter walk test with and without Incedo® (measured in seconds).	—

Measure

Time frame

During the study, evaluations were conducted at five different time points: initially as a baseline (T0), five weeks later as a second baseline (T1), after completing five weeks of therapy (T2), following a 12-week follow-up period (T3), and one year after the intervention (T4). a. 2-minute walk test with and without Incedo® (measured in meters) b. 10-meter walk test with and without Incedo® (measured in seconds).

—

Secondary

Measure	Time frame
a. Video recordings of the patient's gait before and after the training period (T1 and T3). b. Assessment of the sensitivity of the affected foot (at all measurement points from T0 to T4). c. After the training period, a written survey on the acceptance of the therapy device was conducted using the User Satisfaction Evaluation Questionnaire (USEQ) (T3).	—

Countries

Germany

Contacts

Public ContactJoachim Liepert

Kliniken Schmieder Allensbach

j.liepert@kliniken-schmieder.de+4975338081236

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026